Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perfusion MRI in Reversible Cerebral Vasoconstriction Syndrome

NCT02756416 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT02756416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02756416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perfusion MRI in Reversible Cerebral Vasoconstriction Syndrome
Lead sponsor
University of Nottingham
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2016
Completion date
May 31, 2017
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

reversible cerebral vasoconstriction syndrome